Close Menu

LC-MS/MS

With genomic and proteomic profiles for more than 100 colon cancer cases, researchers identified drug targets, treatment resistance insights, potential cancer drivers, and more.

The analysis uncovered established subtypes and added new classifications, while also identifying a potential new treatment target.

Researchers were able to identify 40 tumor-specific antigens within two mouse cancer cell lines and seven human primary tumors using this approach.